Authors/Disclosures
|
Elliot M. Frohman, MD, FAAN
|
Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care. |
|
Noah A. Kolb, MD
(University of Vermont Medical Center)
|
Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for BYRNE CANAAN LAW. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Watson and Spence. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lemmer and Company. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Office of James Feinman. The institution of Dr. Kolb has received research support from National Cancer Institute. Dr. Kolb has received intellectual property interests from a discovery or technology relating to health care. |
|
Gina Remington
|
No disclosure on file |
|
|
No disclosure on file |
|
Jason P. Mendoza, PhD
|
Dr. Mendoza has received personal compensation for serving as an employee of Biogen. Dr. Mendoza has stock in Biogen. |
|
Stephanie Taylor
("Univeristy of Texas, Southwestern")
|
No disclosure on file |
|
Uyen P. Nguyen
|
No disclosure on file |
|
Jaspreet Abraham
(UT Southwestern.edu)
|
No disclosure on file |
|
Katherine Treadaway, LCSW
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Eugene Major, PhD
|
No disclosure on file |
|
Benjamin M. Greenberg, MD, FAAN
(UT Southwestern Medical Center)
|
Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |